221 related articles for article (PubMed ID: 7718644)
1. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
[TBL] [Abstract][Full Text] [Related]
3. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
[TBL] [Abstract][Full Text] [Related]
4. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
5. Resistance of some leukemic blasts to lysis by lymphokine activated killer (LAK) cells.
Panayotides P; Porwit A; Sjögren AM; Wasserman J; Reizenstein P
Eur J Haematol; 1988 Apr; 40(4):362-7. PubMed ID: 3259192
[TBL] [Abstract][Full Text] [Related]
6. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytotoxic lymphocyte subsets against leukemia by stimulation with AML blasts.
Lotzová E; Savary CA
Med Oncol Tumor Pharmacother; 1993; 10(1-2):13-9. PubMed ID: 8258990
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
9. Generation of cytotoxic T lymphocytes from peripheral blood of leukaemic patients.
Nouri AM; Dorey E; Davis CL; Rohatiner A; Lister TA; Oliver RT
Cancer Immunol Immunother; 1993 Jul; 37(1):47-53. PubMed ID: 8513452
[TBL] [Abstract][Full Text] [Related]
10. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
11. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
Sondel PM; Hank JA; Wendel T; Flynn B; Bozdech MJ
J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
[TBL] [Abstract][Full Text] [Related]
12. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
[TBL] [Abstract][Full Text] [Related]
13. A bispecific antibody enhances cytokine-induced killer-mediated cytolysis of autologous acute myeloid leukemia cells.
Kaneko T; Fusauchi Y; Kakui Y; Masuda M; Akahoshi M; Teramura M; Motoji T; Okumura K; Mizoguchi H; Oshimi K
Blood; 1993 Mar; 81(5):1333-41. PubMed ID: 8095165
[TBL] [Abstract][Full Text] [Related]
14. Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.
Schöttker B; Schmidt-Wolf IG
Ger Med Sci; 2011; 9():Doc18. PubMed ID: 21863132
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukaemias and preleukaemic disorders. III. Stage-dependence of oncovirus-specific immune response.
Szabó B; Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
Acta Microbiol Hung; 1986; 33(2):103-10. PubMed ID: 3492851
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
Teichmann JV; Ludwig WD; Thiel E
Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
[TBL] [Abstract][Full Text] [Related]
17. CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.
Steger B; Milosevic S; Doessinger G; Reuther S; Liepert A; Braeu M; Schick J; Vogt V; Schuster F; Kroell T; Busch DH; Borkhardt A; Kolb HJ; Tischer J; Buhmann R; Schmetzer H
Immunobiology; 2014 Apr; 219(4):247-60. PubMed ID: 24315637
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Distler E; Wölfel C; Köhler S; Nonn M; Kaus N; Schnürer E; Meyer RG; Wehler TC; Huber C; Wölfel T; Hartwig UF; Herr W
Exp Hematol; 2008 Apr; 36(4):451-63. PubMed ID: 18261837
[TBL] [Abstract][Full Text] [Related]
19. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
[TBL] [Abstract][Full Text] [Related]
20. Specific recognition of human leukemic cells by allogeneic T cell lines.
Sosman JA; Oettel KR; Hank JA; Fisch P; Sondel PM
Transplantation; 1989 Sep; 48(3):486-95. PubMed ID: 2571206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]